Publications by authors named "Shujun Geng"

Claim this Profile
E
Exosomal cargoes as potential biomarkers for latent tuberculosis infection: a promising frontier in diagnosis?
Haorong Chen, Sijing Liang, Wenli Li, Ting Cao, Shujun Geng

Clin Chim Acta· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China.
Yanhua Song, Wei Shu, Yi Pei, Juan Du, Guihui Wu, Shujun Geng

BMC Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China.
Yanhua Song, Wei Shu, Yi Pei, Juan Du, Guihui Wu, Shujun Geng

BMC Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of Immune-Related Diagnostic Model for Latent Tuberculosis Infection and Active Tuberculosis.
Zhihua Zhang, Yuhong Wang, Yankun Zhang, Shujun Geng, Haifeng Wu

J Inflamm Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety.
Jing-Tao Gao, Juan Du, Gui-Hui Wu, Yi Pei, Meng-Qiu Gao, Shu-Jun Geng

Infect Dis Poverty· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with differential T cell responses to antigens ESAT-6 and CFP-10 in pulmonary tuberculosis patients.
Shengsheng Liu, Meiying Wu, Ertai A, Shucai Wu, Shujun Geng

Medicine (Baltimore)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with negative T-SPOT.TB results among smear-negative tuberculosis patients in China.
Wanli Kang, Meiying Wu, Kunyun Yang, A Ertai, Shucai Wu, Shujun Geng

Sci Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
Wan-Li Kang, Gui-Rong Wang, Mei-Ying Wu, Kun-Yun Yang, A Er-Tai, Shu-Jun Geng

Chin Med J (Engl)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms of CCL1 rs2072069 G/A and TLR2 rs3804099 T/C in pulmonary or meningeal tuberculosis patients.
Yue Zhao, Hui Bu, Kun Hong, Hua Yin, Yue-Li Zou, Shu-Jun Geng

Int J Clin Exp Pathol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of CT-guided percutaneous pulmonary paracentesis and tuberculoma perfusing chemotherapy for the treatment of pleural tuberculosis.
Shujun Geng, Lijuan Li, Jianling Liu, Tao Song

Exp Ther Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells.
Dengrui Li, Sumin Guo, Hui Li, Guiyun Zhu, Li Gao, Shujun Geng

Thorac Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis